Latest Breaking News On - Phase ia clinical study - Page 1 : comparemela.com

Keymed Biosciences | The Latest Results from the Phase Ia Clinical Study of CMG901 was presented at the 2023 ASCO GI CANCERS SYMPOSIUM

United statesKeymed biosciencesDepartment of medical oncologyI keymed biosciences incKeymed biosciences incHong kong stock exchange onSun yat sen university cancer centerLatest resultsPhase ia clinical studyChinai januaryStock codeCancers symposiumAmerican societyClinical oncologyMedical oncologySun yat sen university cancer